Entries by Carme Lopez

The Secretary General for Industry visits the Pharmaloop plant

Mr. Raúl Blanco, Secretary General for Industry and Small and Medium Enterprises, visited Pharmaloop’s new sterile liquids plant, located in Alcalá de Henares (Madrid). Pharmaloop is the first fully autonomous pharmaceutical production center in Spain, with a natural gas cogeneration system that creates its own energy. The visit served to reinforce the company’s commitment to […]

Salvat’s Pharmaloop Invests 65 million Euros in Its New Sterile Liquids Plant, located in Alcalá de Henares

The Minister of Industry, Reyes Maroto, visited Salvat’s new facility today, accompanied by the Mayor of Alcalá de Henares, Javier Rodriguez Palacios and Salvat CEO, Alberto Bueno The new 8,500 m² plant is equipped with the most advanced technology, highest quality standards and the capacity to produce more than 350 million units of sterile formulations […]

Salvat Laboratories enters in the chinese market with Cetraxal® Plus Clinical Trial

Salvat has an agreement with Lee’s Pharmaceuticals to distribute Cetraxal® Plus in China Cetraxal® Plus is the only pharmaceutical product in the world that is available in single-dose vials for external otitis and otitis media. It was launched in 2002 in Spain and is already exported to more than 50 countries The Phase III clinical […]

Herpix®, the new oral formula against the Herpes Simplex Virus from Laboratorios Salvat, is chosen as Product of the Year 2021

The new product from Laboratorios Salvat has been recognised as this year’s most innovative Food Supplement for the Immune System Herpix® is a food supplement formulated from natural extracts which helps slow the replication of the Herpes Simplex Virus (HSV), acting from the inside right from the appearance of the first symptom Herpix®, the new […]

Salvat pioneers advancement in the treatment of non-consolidated bone fractures (BONECURE project)

Salvat’s new BONECURE project is an innovative medical advancement based on pre-differentiated mesenchymal cells designed to treat patients with bone consolidation problems post-fracture (atrophic pseudoarthrosis). A Phase II clinical trial is being completed with promising results in terms of both efficacy and safety, in patients with long bone pseudoarthrosis. Salvat has conducted this project in […]

The Spanish Ministry of Industry maintains the rating of “VERY GOOD” to Laboratorios Salvat SA in the PROFARMA 2019 program

Again this year, Laboratorios Salvat, S.A. has been granted with the rating “VERY GOOD” by the PROFARMA 2019 program of the Spanish Ministry of Industry, which values pharmaceutical companies based on their excellence in Industrial, economic and Research, Development and Innovation activities. This qualification represents an important recognition of Salvat’s continued efforts towards its objective […]

Laboratorios Salvat leads the development of the first treatment for otomycosis

The research, currently underway both in the United States of America and Europe, will involve an investment of more than $10 million. The worldwide launch of the new medicament to treat this type of external otitis, expected for the end of 2021, reinforces Salvat’s positioning in otology at an international level. The company’s international business […]

Salvat and Pharmaloop were present at the CPhI Worldwide 2019

On the 5th, 6th and 7th of November, the city of Frankfurt hosted one of the largest events worldwide in the pharmaceutical industry, bringing together over 45,000 visiting attendees and 2,500 international exhibitors: CPhI Worldwide 2019. Salvat and Pharmaloop teams held numerous meetings with current and potential partners from all over the world of the […]